San Diego, California--(Newsfile Corp. - May 11, 2021) - Kintara Therapeutics, Inc. KTRA today announced that Saiid Zarrabian, President & CEO will be attending the Q2 Virtual Investor Summit.
| Event | Q2 Investor Summit |
| Date | May 17-18th, 2021 |
| Presentation | May 18th at 11:00am ET |
| Location | https://zoom.us/webinar/register/WN_CaBoy6ovRySXUDmri34bUA |
About Kintara Therapeutics, Inc.
Kintara KTRA is dedicated to the development of novel cancer therapies for patients with rare unmet medical needs. Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for glioblastoma multiforme (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).
For further information:
Kintara Therapeutics, Inc.
Jules Abraham
917-885-7378
julesa@coreir.com
About the Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at www.investorsummitgroup.com
Contact:
Sasha Murray at sasha@investorsummitgroup.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
